Drug profile · INN
albiglutide
EPERZAN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
albiglutide (EPERZAN) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN albiglutide
Brand EPERZAN
Route INJECTION
Formulation INJECTABLE
ATC code A10BJ04
Frequently asked questions
What is albiglutide?
albiglutide (EPERZAN) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for albiglutide?
EPERZAN is a marketed brand name for albiglutide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of albiglutide?
albiglutide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.